Rothschild Investment Corp Zynerba Pharmaceuticals, Inc. Transaction History

Rothschild Investment Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 17, 2018	SELL	$5.59 - $10.45 $91,955 - $171,902	-16,450 Closed	0 $0
Q2 2018 Jul 24, 2018	SELL	$7.98 - $12.39 $17,316 - $26,886	-2,170 Reduced 11.65%	16,450 $160,000
Q1 2018 Apr 27, 2018	SELL	$8.49 - $13.46 $83,626 - $132,581	-9,850 Reduced 34.6%	18,620 $162,000
Q3 2017 Oct 25, 2017	BUY	$5.73 - $9.44 $163,133 - $268,756	28,470	28,470 $238,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Rothschild Investment Corp , based on Form 13F filings with the SEC.

Stay updated on Rothschild Investment Corp with notifications on news.